Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pesek

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Neoplasma|March 9, 2016
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinibO Fiala, M Pesek, J Finek, et al.
Neoplasma|August 3, 2013
Erlotinib in the treatment of advanced squamous cell NSCLCO Fiala, M Pesek, J Finek, et al.
Anticancer Research|July 15, 2009
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary diseaseJ Safranek, M Pesta, L Holubec, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II studyP Zatloukal, E Kanitz, P Magyar, et al.
Anticancer Research|July 26, 2007
Tumor markers in pleural effusionsO Topolcan, L Holubec, V Polivkova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2010
[TARCEVA Clinical Registry]J Skricková, M Pesek, P Zatloukal, et al.
Neoplasma|May 10, 2017
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexedO Fiala, P Hosek, M Pesek, et al.
Physical Review Letters|September 5, 2015
Observation of a New Narrow Axial-Vector Meson a1(1420)C Adolph, R Akhunzyanov, M G Alexeev, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Neoplasma|March 9, 2016
Serum albumin is a strong predictor of survival in patients with advanced-stage non-small cell lung cancer treated with erlotinibO Fiala, M Pesek, J Finek, et al.
Neoplasma|August 3, 2013
Erlotinib in the treatment of advanced squamous cell NSCLCO Fiala, M Pesek, J Finek, et al.
Anticancer Research|July 15, 2009
Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary diseaseJ Safranek, M Pesta, L Holubec, et al.
Lung Cancer (Amsterdam, Netherlands)|February 27, 1999
Gemcitabine in locally advanced and metastatic non-small cell lung cancer: the Central European phase II studyP Zatloukal, E Kanitz, P Magyar, et al.
Anticancer Research|July 26, 2007
Tumor markers in pleural effusionsO Topolcan, L Holubec, V Polivkova, et al.
Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti|November 11, 2010
[TARCEVA Clinical Registry]J Skricková, M Pesek, P Zatloukal, et al.
Neoplasma|May 10, 2017
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexedO Fiala, P Hosek, M Pesek, et al.
Physical Review Letters|September 5, 2015
Observation of a New Narrow Axial-Vector Meson a1(1420)C Adolph, R Akhunzyanov, M G Alexeev, et al.
Pageof 6